FORM 8-K

Company

SAB Biotherapeutics, Inc.

Filed

July 3, 2023

Period of Report

June 29, 2023

Accession Number

0001437749-23-019198

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →